Chemoinformaics analysis of 6-HYDROXY-1,2,3,4-TETRAHYDRO-BETA-CARBOLINE-3-CARBOXYLIC ACID
| Molecular Weight | 232.239 | nRot | 1 |
| Heavy Atom Molecular Weight | 220.143 | nRig | 16 |
| Exact Molecular Weight | 232.085 | nRing | 3 |
| Solubility: LogS | -2.87 | nHRing | 2 |
| Solubility: LogP | -1.493 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
| nHA | 3 | APOL | 32.6475 |
| nHD | 4 | BPOL | 14.0465 |
| QED | 0.59 |
| Synth | 3.105 |
| Natural Product Likeliness | 0.728 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.024 |
| CACO-2 | -6.002 |
| MDCK | 0.00000315 |
| BBB | 0.418 |
| PPB | 0.231789 |
| VDSS | 1.086 |
| FU | 0.722893 |
| CYP1A2-inh | 0.067 |
| CYP1A2-sub | 0.225 |
| CYP2c19-inh | 0.076 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.718 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.779 |
| CYP3a4-inh | 0.01 |
| CYP3a4-sub | 0.03 |
| CL | 6.098 |
| T12 | 0.885 |
| hERG | 0.035 |
| Ames | 0.01 |
| ROA | 0.762 |
| SkinSen | 0.605 |
| Carcinogencity | 0.188 |
| EI | 0.024 |
| Respiratory | 0.746 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.737748 |